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ABSTRACT 
Rat  serum  very  low  density  lipoprotein  (VLDL)  inhibits  initiation  of  DNA 
synthesis in fetal rat hepatocyte cultures; cells engaged in synthesizing DNA  resist 
inhibition.  VLDL  action  is specific  and  apparently  blocks prereplicative  protein 
synthesis. These and other results, from studies of altered blood VLDL levels and 
[3H]thymidine  incorporation  into  isolated  liver  nuclei  in  70%  hepatectomized 
normal  and  mutant  hyperlipoproteinemic  rats,  as  well  as  from  infusion  studies 
with  a  "mitogenic"  hormone  solution,  suggest that hepatic VLDL  metabolism is 
linked to the suppression  of hepatocyte proliferation. 
Mammalian  cells  in  culture  usually  display a  re- 
quirement of homologous sera for optimal prolif- 
eration  (17,  37).  However,  primary  cultures  of 
differentiated fetal rat hepatocytes grow poorly in 
media containing adult sera obtained from normal 
or partially hepatectomized rats  (H.  Leffert, un- 
published  results),  thus  preventing  further  com- 
parative  studies  of serum  growth-promoting  ef- 
fects  (22,  33).  While  testing  serum  lipoprotein 
fractions  for  DNA  synthesis  initiation  activity, 
based  upon  previous  studies  implicating  lipids 
among the set of factors initiating cultured hepato- 
cyte DNA synthesis (19, 27), we observed that rat 
serum appreciably stimulated DNA synthesis only 
after  removal  of  bulk  lipoproteins.  This  report 
describes in more detail the basis of this observa- 
tion which  apparently results from the  inhibitory 
action  of one  or  more  components  of very low 
density lipoprotein (VLDL) 1 particles. 
MATERIALS  AND  METHODS 
Reagents 
Materials  required  for primary fetal rat  bepatocyte 
monolayer cultures have been described (22-27). Falcon 
1 Abbreviations used in this paper:  A~so, UV absorbance 
at 280 nm; BSA, bovine serum albumin; dFBS, dialyzed 
fetal bovine serum;  [3H]dT, C[aH]a-thymidine, EDTA, 
sodium  salt  of ethylenediamine  tetra-acetic  acid;  if, 
homozygous "Fatty" mutant Zucker rats; FF, homozy- 
gous wild-type Zucker rats; HDL, high density lipopro- 
tein; LDL, low density lipoprotein; Ta, 3,5,3'-triiodo-L- 
thyronine; TAGH, isotonic saline solution of Ta, amino 
acids, glucagon, and heparin;  TCA, trichloracetic acid; 
VLDL, very low density lipoprotein. 
20  TIIE JOURNAL OF  CELL BIOLOGY " VOLUME 70,  1976  " pages 20-32 dishes  (35-mm  plastic  style,  Falcon  Plastics,  Div.  of 
BioQuest, Oxnard, Calif.) were used to obviate toxicity 
problems  encountered  with  contemporary  NUNC 
dishes. Sera were purchased from Grand Island Biologi- 
cal Co., Santa Clara, Calif. Isotopes from New England 
Nuclear  Corp.  (Gardena,  Calif.)  included:  o-[3-O-C- 
3H]a-glucose,  sp act 4-5  Ci/mmol; L-[3-aH]arginine, sp 
act 20-40 Ci/mmol; and C[aH]~-thymidine ([aH]dT), sp 
act  18-20  or  40-50  Ci/mmol.  T3  and  bovine serum 
albumin (BSA) and heparin (100 U  per mg) were pur- 
chased from Sigma Chemical Co., (St. Louis, Mo.) and 
Nutritional Biochemical (Cleveland, Ohio), respectively. 
Porcine glucagon was a gift from Dr. W. Bromer, Lilly 
Research Laboratories,  Indianapolis, Ind. AR10 strip- 
ping film was obtained from Eastman Kodak Co., Roch- 
ester, N. Y.; Sephadex G-100 (40-120 /.Lm) and (3-25 
(fine)  were  obtained  from  Pharmacia  Chemical  Co., 
Piscataway,  N.  J.  Bio-Solv  and  Liquifluor  were  pur- 
chased  from  Beckman  Instruments  (Fullerton,  Calif.) 
and New England Nuclear, respectively. 
Animals 
Adult Fisher/344 male (180-200 g) and 19- to 21-day 
pregnant  female  rats  were  purchased  from  Simonsen 
Labs, Giiroy, Calif. Male rats of the strain Rattus norveg- 
icus carrying the "Fatty" gene (55) were obtained from 
the Harriet G. Bird Memorial Laboratory, Stowe, Mass. 
Homozygous  wild-type  (FF)  and  homozygous  "Fatty" 
mutant (fO  Zucker rats weighed 206  -  57 (SD) g and 
302 •  46 (SD) g, respectively. All animals were housed 
at 21~  three to four per cage, fed standard Purina lab 
chow and H20 ad lib,  and accommodated to light be- 
tween 0800 and 2000 h. 
Preparation  of Sera 
Left-ventricular blood was obtained under ether anes- 
thesia, clotted at 4~  and centrifuged at 6,000 g for 30 
min at 4~  Unless otherwise noted, blood samples from 
70%  hepatectomized  or  laparotomized  rats  were  col- 
lected 6 h after surgery, and from infused rats as noted 
(Table  II).  Fetal  bovine sera  (FBS)  were  heat-inacti- 
vated, dialyzed, and stored as previously described (23). 
Protein concentrations were obtained by A2ao measure- 
ments or with the Folin reagent (31). 
Preparation of Serum Lipoprotein 
Fractions and Lipoprotein- 
Deficient  Serum 
Rat lipoprotein fractions were isolated by sequential 
density ultracentrifugation with an SW-41  rotor (Beck- 
man)  at  180,000  g  according to  standard  procedures 
(14). Pooled VLDL (free of chylomicra, d <  1.006 g/ml) 
was washed by two additional centrifugation cycles  at d 
=  1.006  in  0.15  M  NaCI-0.01%  (wt/vol) ethylenedi- 
amine tetra-acetic acid (EDTA).  LDL and HDL were 
isolated after adjustment of the d  =  1.006 infranatant to 
appropriate densities with solid NaBr: fractions 1.006 > 
d  <  1.050 and  1.050  >  d  <  1.21  were designated as 
LDL and HDL, respectively. Lipoprotein-deficient sera, 
prepared as described elsewhere (53), contained <0.5% 
of the initial serum cholesterol concentration as deter- 
mined by gas-chromatographic analysis. 
Resulting  fractions and  sera  were  dialyzed  exhaus- 
tively at 4*(2 against 0.15 M NaCI with or without 0.01% 
EDTA. Fractions were sterilized by passage through 0.4- 
/~m filters (Millipore Corp., Bedford, Mass.) and stored 
at 4~  Dialysates also were  collected and bioassayed 
(see Fig.  3). 
V LD  L  Protein-Phospholipid 
Particle Isolation 
Water-soluble neutral lipid-free rat VLDL  particles 
were  prepared  by  a  partial delipidation method  (13). 
After 6 n-heptane extractions at -12~  VLDL protein 
recovery was 50-70%. Lipid analyses (51) showed that 
< 1% of VLDL triglyceride and cholesterol and 25-35 % 
of  VLDL  phospholipid  remained  associated  with  the 
extracted "apoprotein" particles. 
V L D L- Lipid Isolation 
All  operations  were  performed  at  4~  with  glass- 
distilled  solvents  and  acid-washed  glassware.  2  ml  of 
VLDL (3.3  mg protein/ml) were extracted four times 
with 6 vol of chloroform-methanol (1:1), and the result- 
ing lipid extracts were washed as previously described 
(51,  52).  Extracts were  partitioned into an  "aqueous 
wash"  fraction,  shown  to  contain  water-soluble  non- 
lipids, traces of acidic phospholipid and ganglioside (if 
present in the sample), and into a lipid-soluble fraction 
containing aa neutral and polar lipid. This fraction was 
purified further by Sephadex G-25 chromatography be- 
fore separation into neutral lipid, glycolipid, and phos- 
pholipid classes with a silicic acid column (52). 
Mild alkaline hydrolysis of dried  lipid fractions was 
performed  at  37"C  for  3  h  in  0.1  N  KOH  in  95% 
ethanol. Saponified samples were acidified (0.2 ml of 12 
N HCI) and extracted with hexane to remove free fatty 
acids; water-soluble products were neutralized and sub- 
sequently tested for biological activity. 
A  volume of phosphate-buffered saline equivalent to 
the volume of VLDL extracted was added to each dried 
lipid fraction and sonicated for 30 s at maximum inten- 
sity  (Branson  Microtip Sonicator,  model  140D,  Heat 
Systems-Ultrasonics, Inc., Plainview, N.Y.). Lipid emul- 
sions were stored at 4~  and bioassayed within 12 h of 
preparation.  Parallel  mock  0.15  M  NaCI  extractions 
were bioassayed to control for residual contamination of 
fractions by solvents or by trace impurities ("diluent", 
see Fig.  6). 
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Lipoprotein-Deficient Rat Serum 
90 ml of sera (A2s0 U/ml =  64; ca. 54 mg protein/ml) 
from normal or  70%  hepatectomized rats were  made 
lipoprotein-deficient (53) and adjusted to initial volumes 
with 0.15  M NaCI (A2s0 U/ml =  52). Solid (NH4)2SO4 
was added to 80 ml of this material (~<4 tzg cholesterol/ 
ml) at 4"C with constant stirring to obtain these fractions 
(percentage of saturation): 0-30; 30-50; 50-70; 70-80; 
and I>80.  Fractions were dialyzed exhaustively against 
0.15  M  NaCI;  total  protein  recovery  was  85-90%. 
Bioassay  revealed  that  >80%  of  in  vitro  hepatocyte 
DNA  synthesis  initiation-activity  (19)  was  present 
throughout  fractions  />50%  saturation  (27).  Two  of 
these  were  boiled  (50-70%,  5  rain; 70-80%  1  min), 
clarified by centrifugation at 15,000g for 30 min at 4~ 
and  both  supernates  were  combined with  the  />80% 
fraction  (whose  activity  was  heat  labile).  Precipitated 
material which formed after boiling was biologically inac- 
tive.  Pooled  active material was  dialyzed  exhaustively 
against H20 at 4~  lyophilized, and resuspended in 10 
ml 0.15 M NaCI. This fraction represented 8-10% of the 
starting protein (A2so U/ml =  35-40) and was used for 
gel filtration. 
Gel Filtration 
All operations were performed at 4~  A glass column 
(1.5  ￿  90 cm) was packed with Sephadex G-100 equili- 
brated in 0.05 M phosphate buffer, pH 7.4. The ammo- 
nium sulfate fraction for chromatography (A~0 U/ml 
36, 4.8 ml) was dialyzed against and eluted with similar 
buffer. Calibration, collection of column fractions, and 
protein  recoveries  were  carried  out  as  previously  de- 
scribed (25). 
DNA Synthesis  Bioassays 
12-day old G~l-arrested hepatocyte cultures were pre- 
pared and initiation assays performed as previously de- 
scribed  (19),  except  that  2.3  ￿  10  ~ cells/dish  were 
seeded. DNA synthesis rates at 22-24 h and the percent- 
age  of ceils  entering S  phase  (i.e.,  "recruited")  were 
determined by standard [3H]dT (sp act 18-20 Ci/mmol) 
pulse-labeling and radioautographic techniques, respec- 
tively (19), unless otherwise noted. Quiescent 3T3 and 
fetal rat fibroblast cultures were established, and DNA 
synthesis initiation assays were performed as described 
elsewhere  (17,  48);  methods for culturing SV400virus 
transformed 3T3 cells have been described (17). 
DNA synthesis was stimulated in intact rats by a 300 
rain tail vein infusion of 5  ml of TAGH solution (42) 
containing 3,5,3'-triiodo-e-thyronine (T3) (100 t~g), glu- 
cagon (1 rag) and heparin (100 U), pH 7.4. Amino acids 
used were a  50￿  concentrate (in 0.15 M  NaCI) of the 
complete  mixture present in ceil culture  medium  (22, 
23). The infusate was delivered to animals in Bowman 
cages  from  a  10-ml  syringe  fixed  to  a  constant  flow 
infusion pump (Sage Instruments Div., Orion Research 
Inc., Cambridge, Mass.).  Control rats received a  5-ml 
saline infusion. 
DNA synthesis rates were determined in normal and 
mutant rats (after 70% or sham hepatectomy) or in the 
infused animals 22-24 h after surgery. Operations were 
performed  under  ether  anesthesia between  0900  and 
1200 h as previously described (29). [3H]dT (sp act 40- 
50 Ci/mmol; 50 tzCi/kg body weight) was administered 
intrajugularly; nuclei were prepared from caudate  and 
accessory lobes (2). Nuclear aliquots (500/~1) were pre- 
cipitated by cold 5% voi/vol trichloracetic acid (TCA) 
onto Whatman GF/C filters, and radioactivity was deter- 
mined by scintillation counting (19). DNA was quanti- 
tated by the diphenylamine reaction (7). 
In Vitro  Cell Counts 
Attached cells were  trypsinized and counted  with a 
Coulter  Counter  (Coulter  Electronics,  Inc.,  Hialeah, 
Fla.) (22-27). 
In Vitro Precursor  Uptake Studies 
Labeled precursors were  added to cultures ca.  24 h 
after initiating DNA synthesis. Media were aspired after 
30 min, and the monolayers were washed three times 
with 2 ml of ice-cold Tris-saline, pH 7.4, and extracted 
with ice-cold TCA (19). For [3H]dT uptake experiments 
(2.5  t~Ci/culture; sp act  18-20 Ci/mmol), acid-soluble 
extracts were pooled from three replicate cultures; the 
proportion of [aH]dT incorporated into d'ITP was quan- 
titated by PEI-cellulose chromatography (34). For argi- 
nine and 3-O-methyl-v-glucose uptake studies (2.0 and 
1.0/~Ci/culture, respectively), cultures were washed two 
times with 2 ml of prewarmed precursor-free and serum- 
free medium after which 2 ml of similar isotope-contain- 
ing media were added with or without the initial dFBS 
and/or VLDL supplements. Acid-soluble radioactivity in 
0.5 ml of extract was determined by scintillation count- 
ing of samples dissolved in 10 ml of Bio-Soiv: Toluene: 
Liquifluor (100  ml:  1,000  ml: 42  ml) cocktail.  Under 
these conditions, tritium is counted with ca.  50% effi- 
ciency.  In these experiments, each datum  is the mean 
value of duplicate pools (Fig. 3) or single extracts from 
triplicate cultures (Fig. 5). Protein synthesis rates were a 
measure of heat-stable acid-insoluble radioactivity which 
remained in TCA-extracted monolayers (19). 
Data Analysis 
For in vitro experiments, unless otherwise noted, each 
datum is the mean -  10% of triplicate cultures. Statisti- 
cal significance (Mann-Whitney U Test; Multiple Range 
Tests of Dunnett or Duncan) was determined with the 
UCLA IBM-360 Computer (model 95) and computer 
program EXBIOL. 
RESULTS 
Initiation  of In Vitro Hepatocyte  DNA 
Synthesis  by Native and by Fractionated 
Rat Sera 
Homologous  adult  rat  serum  poorly  initiated 
DNA  synthesis  in  G~l-arrested  hepatocyte  cul- 
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FIOUgE  1  Initiation of in vitro hepatocyte DNA syn- 
thesis  by native  and  by lipoprotein-deficient  rat sera. 
DNA  initiation  bioassays  were  performed and  DNA 
synthesis rates determined as described in Materials and 
Methods. Basal incorporation  rates (serum-free  media 
additions = 200 cpm/culture) were subtracted from plot- 
ted data; 15% vol/vol dFBS additions (positive controls) 
gave  1,600 cpm/culture.  Sera tested (A~0 ~  60-65 U/ 
ml) included: native rat serum (@- @); lipoprotein-defl- 
cient sera obtained from normal or 70% hepatectomized 
animals (i- II); and lipoprotein-deficient normal serum 
repleted with 40  /zg VLDL protein/ml  ([3--Q). Ordi- 
nate:  [3H]dT incorporated (cpm/culture).  Abscissa: se- 
rum A~o U added/ml medium. 
tures  (Fig.  1).  [3H]dT incorporation under these 
conditions, a measure of cellular recruitment into 
S  phase  (19),  was  about  doubled,  z  Serum  ob- 
tained 6 h after 70% hepatectomy enhanced DNA 
synthesis (33) but, compared to sera from normal 
or  sham-hepatectomized  rats,  only  by  40-50% 
(data  not  shown).  Similar results were  obtained 
with dialyzed rat sera. By contrast, dFBS was >16 
times more active than  native rat sera, as deter- 
mined from slopes of log-dose response curves. 
While attempts were being made to fractionate 
Earlier studies were conducted under nonarrested  cul- 
ture  conditions  so  that  increased  incorporation  rates 
probably reflected  accelerated  rates of ongoing  DNA 
synthesis (33). 
rat sera, lipids were observed to promote initiation 
of DNA synthesis in this system (19, 27). There- 
fore,  the  bulk serum lipoprotein fraction, which 
carries most serum lipids, was isolated and tested 
for biological activity. This fraction was nonstimu- 
latory over a  broad concentration range (10-400 
tzg protein/ml medium) and actually inhibited ini- 
tiation of DNA synthesis ca.  25%  at concentra- 
tions >200  tzg protein/ml medium  (not shown). 
However,  the  lipoprotein-deficient  fraction 
showed  three-  to  fourfold increased stimulatory 
activity (Fig. 1). This figure also shows that lipo- 
protein-deficient sera from  70%  hepatectomized 
rats gave results identical to those obtained with 
lipoprotein-deficient normal sera. These observa- 
tions suggest that enhanced DNA synthesis initia- 
tion by partially hepatectomized rat sera resulted 
from differences in the level of inhibitory material 
present in the lipoprotein fraction. 
This  hypothesis is  supported  by  the  apparent 
identity between  gel  filtration profiles of DNA 
synthesis initiating activity recovered from pooled 
ammonium  sulfate  fractions  of  lipoprotein-defi- 
cient sera obtained from either 70% hepatectom- 
ized or normal rats (Fig. 2): Two peaks of stimu- 
latory activity eluted: the first appeared in the void 
volume;  the  second spread  over many  fractions 
which eluted after BSA and contained little A~0 
absorbing material. 
Specific  Inhibition of lnitiation  of In Vitro 
Hepatocyte  DNA  Synthesis  by  Rat  Serum 
VLDL 
Fig.  3  shows  that  cellular recruitment  into  S 
phase  stimulated  by  lipoprotein-deficient dFBS 
was inhibited specifically by VLDL at microgram 
concentrations. Only slight inhibition was caused 
by LDL  or by HDL,  or by lipoprotein fraction 
"dialysates" (0.3 ml/culture). The extent of inhibi- 
tion  could  be  accounted  for  neither by  cellular 
detachment (~< 10% in all cases) nor by inhibition 
of [3H]dT uptake into total acid-soluble or dTI~ 
3 Chromatograms  of  native  rat  sera,  obtained  from 
either 70%  hepatectomized  or normal rats, produced 
similar qualitative  results compared to lipoprotein-defi- 
dent sera, with these exceptions: (a) stimulatory activity 
present in  peak I  material was generally 65-75%  re- 
duced, presumably due to the presence of high molecular 
weight inhibitory material (see Fig. 3); and (b) the pres- 
ence of stimulatory activity in the region of peak II was 
variable, presumably due to trailing of inhibitory activity 
throughout  the column. 
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FIOUaE 2  Initiation of in vitro hepatocyte DNA synthesis by lipoprotein-deficient rat sera fractionated 
by ammonium sulfate and gel filtration. Bioassays  were performed and data plotted as described in Fig. 1 
(basal incorporation rates =  200 cpm/culture; 15%  vol/vol dFBS =  1,600 cpm/culture; 15% vol/vol 
lipoprotein-deficient normal rat  serum  =  840 cpm/culture). Column fractions added  to  the  cultures 
(r]--E3, 0.05 ml; O--O, 0.20 ml) were derived from sera obtained from normal or 70% hepatectomized 
rats  3 and were prepared as described in Materials and Methods; protein concentrations were determined 
spectrophotometrically (A- A). BSA standards eluted in fractions no. 18-27. Left ordinate: A=80 U. Right 
ordinate: [aH]dT incorporation (cpm/culture). Abscissa: column fraction no. 
pools.  For example, at VLDL concentrations of 
6-30/zg protein/ml, [3H]dT uptake into bulk acid- 
soluble material was  inhibited 40-50%  whereas 
recruitment was inhibited 50-99.9% (Fig. 3); un- 
der similar conditions, VLDL did not alter distri- 
bution of [3H]dT  uptake into dTs  (ca. 60% of 
the  total counts). LDL  and  HDL  fractions also 
inhibited [3H]dT uptake into the acid-soluble frac- 
tion  by  30-40%  but  not  recruitment  (Fig.  3); 
apparently, material common to each lipoprotein 
fraction  inhibits  [3H]dT  uptake.  Similar results 
were obtained using native dFBS to initiate DNA 
synthesis.  Additional controls  showed  that  85- 
90%  of the attached cells were  viable under all 
conditions (23)  and that VLDL  lipoprotein nei- 
ther absorbed nor degraded [3H]dT (25). 
Three  other  systems were  used  to  determine 
cellular  specificity,  including SV3T3,  quiescent 
3T3,  and  primary  fetal  rat  fibroblasts.  VLDL- 
supplementation at saturating levels (40 /~g pro- 
tein/ml medium) promoted SV3T3 proliferation, 
determined  by  cell  counts  (H.  Leffert  and  D. 
Young,  unpublished results)  but  neither stimu- 
lated nor inhibited serum-initiated DNA synthesis 
in the other tested cultures. 
Additional experiments indicated that  VLDL 
acted similarly when added at saturating levels to 
lipoprotein-deficient rat  serum-induced cultures 
(Fig.  1).  However,  the  observed  inhibition by 
VLDL (50-60%) was less than that obtained with 
FBS-induced cultures. Native (normal) rat serum- 
induced DNA synthesis (Fig.  1) was not further 
diminished in similar repletion studies. 
Temporal Sensitivity to VLD  L-Inhibition 
of Initiation of In Vitro Hepatocyte 
DNA Synthesis 
The  quantity of DNA synthesized by G0.~-ar- 
rested cultures 22-24 h  after induction by  10% 
vol/vol dFBS  is  proportional to  serum-exposure 
time: 0-12 h produced synthesis rates 90-95% of 
maximal whereas shorter times (0-4 and 0-8 h) 
produced  proportionately lower rates  (36%  and 
70%, respectively [26]). Because these "commit- 
ment" experiments reflected proportions of ceils 
recruited to synthesize DNA (26), it was of inter- 
est to determine whether VLDL affected prerepli- 
cative events involved with  "commitment" proc- 
esses. 
Fig. 4 shows that VLDL inhibited initiation of 
DNA synthesis to  quantitative extents predicted 
from  10%  vol/vol  dFBS  commitment  experi- 
ments. For example, the presence of VLDL dur- 
ing the prereplicative phase from 0 to 4, 0 to 8, or 
0 to  12 h permitted ca. 64, 30, or 5-10% of the 
maximal response, respectively. The results (Fig. 
4) also suggest that VLDL action was independent 
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FIGURE  3  Specific inhibition of initiation of in vitro hepatocyte  DNA  synthesis by rat  serum  VLDL. 
Three sets of quiescent cultures received fresh medium changes together with  10%  vol/vol lipoprotein- 
deficient dFBS and varying concentrations (/zg lipoprotein-protein/ml medium, abscissae) of VLDL (left 
panel),  or LDL  (middle panel), or HDL  (right panel).  Each culture set then was subdivided into three 
bioassay groups. The fraction of DNA-synthesizing cells 23.5-24 h later was determined by autoradiogra- 
phy. Each point (O -  t,  [left ordinate], labeled nuclei) is the average of duplicate cultures, 1,000 cells/dish 
scored. Control values were: minus serum =  3%; plus serum -+ 0.3 ml lipoprotein fraction "dialysates" = 
23% ("100%" points). The rate of [SH]dT uptake into TCA-soluble material (group two) was determined 
between 23.5 and 24 h (B-I,  [fight ordinate], acid-soluble cpm). Control values were: minus serum = 
2,500 cpm; plus serum --* 0.3 ml "dialysates" =  8,800 cpm (100 % points). Attached numbers of cells were 
determined (third group) by trypsinization (A-A,  [extreme right ordinate]). Control values were: minus 
serum  =  30,000 cells/dish; plus serum  -  0.3 ml "dialysates"  =  31,000 cells/dish (100%  points). 
of initial  serum  concentrations.  DNA  synthesis 
rates  observed  at  22-24  h  were  consistent with 
above predictions when VLDL was added at 0, 4, 
8,  and  12  h  (not  shown).  VLDL  did not block 
ongoing DNA synthesis because it failed to inhibit 
[aH]dT incorporation into DNA when added dur- 
ing  the  labeling  interval  (Fig.  4).  Therefore, 
VLDL appeared to act only upon cells initiating 
DNA synthesis. 
In Vitro Inhibition  of Prereplicative 
Protein Synthesis by VLDL 
Previous  studies  suggested  that  membrane 
events associated with arginine incorporation into 
protein beyond those involved with  arginine up- 
take into an acid-soluble pool were important in 
growth regulation (19, 26, 27). Therefore, it was 
of interest to determine VLDL effects on arginine 
utilization after dFBS-induced DNA synthesis. 3- 
O-Methyl-D-glucose uptake also was measured be- 
cause  this  precursor  is not  significantly metabo- 
lized and therefore serves as a probe for measur- 
ing transport (50). 
Fig.  5  shows  that  VLDL  had  no  detectable 
effect on uptake of either precursor into the acid- 
soluble  fraction;  nevertheless,  significant  inhibi- 
tion (60-70%) of serum-induced protein synthesis 
was  observed.  Therefore,  the  effects  of  VLDL 
were qualitatively similar to those observed with 
glucagon  4 but  considerably more  efficient  (27). 
Additional parallel studies, in  which comparison 
was  made  between  the  quantity  of  [3H]arginine 
remaining  precipitable after  cold  and  hot  TCA 
4 We have been unable to detect immunoreactive gluca- 
gon as a contaminant of our VLDL preparation. 
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Inhibition  of initiation of in vitro hepatocyte  FIGURE  4 
DNA synthesis  as a function of VLDL exposure-time. 
Go.l-arrested  cultures were  changed  to  fresh  medium 
supplemented with dFBS (0, or 2.5, or 5.0 or 10.0% 
vol/vol)  and VLDL  (40  ttg protein/ml). The cultures 
were subdivided into groups and, at the indicated times 
(4, I-@;  8, &-&; or 12 h, I-I  later), media were 
aspired, washed twice with 2 ml serum-free medium, and 
re-incubated with fresh (370C) media supplemented with 
the respective  initial serum concentrations. Additional 
cultures received 40/,g VLDL protein/ml continuously 
(@-@) or at 22 h (]~-][). DNA synthesis rates were 
determined  as  described  in  Materials  and  Methods. 
"100%  serum controls" were:  minus serum (140 cpm/ 
culture); 2.5% (600 cpm/culture); 5.0% (800 cpm/cul- 
ture) and 10.0%(1,100 cpm/culture). Ordinate: [aH]dT 
incorporation (%  control).  Abscissa:  %  initial dFBS 
concentration. 
washing, argue against VLDL-inhibition of tRNA 
charging because the proportion of tritium in pro- 
tein (55-60%) and in tRNA (40-45%) was inde- 
pendent of the presence or absence of VLDL. 
Partial Purification of Initiation Inhib itors 
from VLDL Particles 
Fig. 6 shows that the total VLDL-lipid fraction 
was approximately as potent as native VLDL and 
ca.  10  times  more  active  than  VLDL  "apopro- 
tein". Mild saponification reduced activity of the 
lipid fraction  I>80%,  suggesting involvement of 
esterified lipid(s). Both phospholipid and aqueous 
wash fractions showed considerable inhibitory ac- 
tivity whereas  neutral lipids, which comprise the 
bulk VLDL  lipid (20),  were  inactive. A  neutral 
glycolipid fraction (containing some acidic phos- 
pholipids) showed some inhibitory activity, hut its 
potency  was  considerably  less  than  those  of 
aqueous  wash  and  total  phospholipid  extracts. 
Bulk LDL and HDL lipid fractions were inactive 
(not shown). 
Serum Lipoprotein  Changes in Adult Rats 
aider 70% and Sham Hepatectomy 
Fig.  7  shows  that  70%  hepatectomy  induced 
specific  prereplicative  alterations  in  serum  lipo- 
protein  levels.  Within  3  h,  VLDL  levels  fell 
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FIOUV.E  5  VLDL  inhibition  of  serum-stimulated  pre- 
replicative  protein synthesis in hepatocyte cultures. Ar- 
rested cultures were changed to fresh medium containing 
dFBS (0, or 2.5, or 5.0 or 10% vol/vol, abscissae) with 
(dashed  lines) or  without  (solid  lines) 40  /~g VLDL 
protein/nil medium. Precursor uptake and protein syn- 
thesis  rates  were  measured  24.0-24.5  h  later  as  de- 
scribed in Materials and Methods. TCA-soluble (circles) 
and  hot-TCA-precipitable  (squares)  radioactivity  are 
shown on the ordinates: [3-O-C-all]a-glucose (top right) 
and L-[3-aH]arginine (bottom left). 
26  ThE  JOURNAL  OF  CELL  BIOLOGY " VOLUME  70,  1976 surgery  with  similar groups  of rats  in  a  separate 
~oo  study (27). 4-5 days after surgery, VLDL levels in 
-  ~ .........  o  the 70%  hepatectomized group were 55-65%  of 
'~  ~,~__~_~  those initi  ally present. 
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FI6URE 6  Partial  purification  of  VLDL  components 
inhibiting  initiation of in vitro hepatocyte DNA synthe- 
sis. G0.l-arrested  cultures were changed to fresh medium 
containing  10%  vol/vol dFBS  together  with  various 
VLDL  particle  fractions  (0-300  /zl,  abscissa):  native 
VLDL (t-  @); total lipid (O-@); saponified total lipid 
(&-A);  neutral  lipid  (O-O);  neutral  glycolipid  plus 
acidic phospholipid (O-O); aqueous wash (*-*);  to- 
tal  phospholipid  (t-O);  and  VLDL  "apoprotein" 
(E3--E3). DNA synthesis  rates were determined as de- 
scribed in Materials and Methods. Control values were: 
minus serum  =  240 cpm/culture; plus serum  -+ 0.3 ml 
"diluent"/culture =  1,100  cpm/culture (100%  points). 
Ordinate: [3H]dT incorporation (% of control). 
>80%,  significantly less (P  <  0.05)  than VLDL 
levels in  ether anesthetized  or sham-hepatectom- 
ized  animals  (VLDL  levels  in  these  latter  two 
groups were statistically similar). VLDL levels in 
70%  hepatectomized  rats  remained  significantly 
lowered  but,  in  the  control  groups,  the  serum 
levels rose four- to fivefold within 6 h (P <  0.01). 
Although  HDL  appeared  to  vary  diurnally,  no 
other  differences  among  the  three  groups  were 
observed from 0 to 24 h. Fig. 7 also shows that, 12 
h after surgery, LDL levels in both laparotomized 
and 70% hepatectomized groups were higher than 
those of anesthetized animals (P <  0.05)? These 
observations are similar to those made  12 h  after 
'~ Reciprocal changes between VLDL and LDL also have 
been noted under different conditions (54). 
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FIGURE  7  Rat serum lipoprotein levels after 70%  or 
sham hepatectomy and after ether anesthesia. Rats were 
70%  (&-&)  and  sham  hepatectomized (O--O),  or 
briefly  etherized  (1~-@),  and  at  varying  times  (ab- 
scissae), three to four animals per group were anesthe- 
tized and serum samples prepared for lipoprotein deter- 
minations  (ordinates)  as  described  in  Materials  and 
Methods (VLDL [top panel]; LDL [middle  panel]; and 
HDL  [bottom  panel]).  Food,  but  not  water,  was  re- 
moved from the cages; "zero-time" (0900 h) determina- 
tions were made from unstarved animals. Statistical anal- 
yses  showed  significant  differences  for  the  following 
data: VLDL, 70% hepatectomized vs. both sham hepa- 
tectomized and etherized rats  at 3,  12, and 24 h, P  < 
0.05 and at 6 h, P  <  0.01; LDL, both 70% heptatecto- 
mized and sham hepatectomized vs. etherized at 12 h, P 
<  0.05. At 12 h, all groups of animals had significantly 
higher serum levels of HDL compared to 3-, 6- or 24-h 
levels (P <  0.01). 
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Rates in Fatty Rats a]ier 
70%  Hepatectomy 
A  mutant rat strain (Fatty) which overproduces 
VLDL  and,  consequently,  is  hyperlipoprotein- 
emic  has been  developed  and characterized  (38, 
39, 55, 56). Table I shows that, after 70% hepa- 
tectomy,  hepatic  DNA  synthesis  rates  in  these 
animals were fourfold less than those in wild-type. 
This  difference  correlated  inversely  with  initial 
serum VLDL levels which were three- to fourfold 
higher in the mutants; however, both groups had 
significantly lower VLDL  levels 24  h  postopera- 
tively, as is shown in Table I. 
Serum  VLDL  Levels and DNA  Synthesis 
Rates in Rats Infused with a 
TAGH  Solution 
Table  II shows that, under our infusion condi- 
tions,  the  TAGH  solution  stimulated  hepatic 
DNA  synthesis  rates  fivefoid  and  markedly  de- 
creased  serum  VLDL  levels  within  30  rain,  in 
comparison  to  saline-infused groups (P  <  0.01). 
By  6  h,  serum  VLDL  levels returned  to  control 
values, and further decreases (through 24 h) were 
not observed.  Repeated  or more  prolonged infu- 
sions produced both delayed and depressed stimu- 
lation of hepatic DNA  synthesis; VLDL  was not 
measured under these conditions. 
DISCUSSION 
A  controversial  literature  surrounds  the  concept 
that blood-borne factors of hepatic origin specifi- 
cally suppress normal hepatocyte proliferation (5, 
12, 35). Evidence for their existence in both blood 
and  hepatocytes,  however,  is  lacking  (47),  and 
their physiological changes, if any, during in vivo 
hepatoproliferative transitions are unknown (43). 
We describe here direct evidence that purified rat 
VLDL-  a circulating lipoprotein produced mainly 
by adult liver (18, 46) under hormonal control (8, 
TABLE  I 
DNA Synthesis Rates and Serum VLDL Levels in Genetically Obese Fatty Rats alter 70% Hepatectomy 
Serum VLDL* 
Manipulation  Genotype  0 h  24 h  DNA synthesisr 
70% Hepatectomy  FF  52 (3)  31  (4)  11,597 (9) 
70% Hepatectomy  ff  167 (5)  42 (5)  2,643 (9) 
Mutant "Fatty" rats and wild-type littermates were 70% hepatectomized immediately after sampling 1 ml blood. 
Food, but not water, was removed from the cages, and hepatic DNA synthesis rates and serum VLDL levels were 
determined as described in Materials and Methods. 
* /~g protein/ml. Data show the mean values (number of rats shown in parentheses) and were analyzed by Multiple 
Range Tests of Dunnett or Duncan. P <  0.05 (FF at 0 h vs. FF at 24 h) and P <  0.01 (ff at 0 h vs. FF at 0 h or ff at 24 
h). 
:~ cpm/mg DNA/2 h pulse, 22-24 h postsurgery. Data were analyzed by the Mann-Whitney U Test, P <  0.02 (FF vs. 
ff). 
TABLE II 
Serum VLDL Levels and DNA Synthesis Rates in Rats Infused with a TAGH Solution 
Serum VLDL* 
Infusate  0 h  0.5 h  1 h  3 h  6 h  DNA synthesis:~ 
TAGH  96 -+  12  7  -  2  11  --- 4  79 -  13  61  •  10  2,299 --- 370 
Saline  -  86 -+ 21  154 •  18  105  -+ 8  69 •  14  430 ---  116 
Intact rats received infusions as described in Materials and Mettiods. Serum samples were obtained at various times 
after starting ("0 h"), and VLDL and hepatic DNA synthesis rates were determined as described in Materials and 
Methods. 
* Mean [/~g protein/ml] -+ SEM, obtained from four rats per group and were analyzed by Multiple Range Tests of 
Dunnett or Duncan: P  <  0.01 (TAGH vs. saline at 0.5 and 1 h); P  <  0.05 (TAGH vs. saline at 3 h); not significant 
(TAGH vs, saline at 6 h); saline at 1 h was significantly higher than at all other times (P <  0.01). 
cpm/mg DNA/2 h pulse, 22-24 h postinfusion. The data are mean values •  SEM from five rats per group and were 
analyzed with the Multiple Range Test of Dunnett (P <  0.01). 
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synthesis in differentiated cultures of fetal rat hep- 
atocytes  (22-27,  40).  Indirect  in  vivo evidence 
strongly associating VLDL (and/or its related me- 
tabolism)  with  suppression  of hepatic  G0.~ ~  S 
transitions also has been obtained. The control of 
animal  cell  proliferation  and the role  that "chal- 
ones" may play in these processes have been dis- 
cussed elsewhere (28). 
In  vitro  findings  that  VLDL  more  efficiently 
inhibits  DNA synthesis initiated  by FBS (Fig. 3) 
than  by  lipoprotein-deficient  rat  serum  (Fig.  1) 
may involve greater stability of VLDL-particles in 
fetal  serum,  and/or  "blocking"  effects  of addi- 
tional serum lipoproteins (36) or other serum fac- 
tors.  Similar  explanations  hold  for  the  findings 
that  excess  VLDL fails  to  further  diminish  low 
levels  of DNA  synthesis  induced  by normal  rat 
serum. Further observations (Fig. 2) that lipopro- 
tein-deficient  rat  serum  fractions-derived  from 
normal  or  70%  hepatectomized  rats-produce 
identical  biological  activity  profiles  suggest  that 
DNA  synthesis  initiation  factors  normally  are 
present in blood. This statement is consistent with 
previous in vitro and in vivo observations (6, 26- 
30, 42, 45), but proof of identity requires further 
chemical  characterization.  Although  identity be- 
tween rat VLDL and the DNA synthesis-initiation 
inhibitory  factor(s)  present  in  dFBS  (25)  is  un- 
likely, this conclusion must also remain tentative 
pending further study. 
In vitro experiments suggest that VLDL acts by 
inhibiting prereplicative protein synthesis required 
for initiating  DNA synthesis  (Figs. 4  and  5) and 
not by inhibiting tRNA charging or the uptake of 
at  least  one  nutrient-arginine-known  to  limit 
growth in this system (Fig. 5  [19]). Partial purifi- 
cation of inhibiting material(s) implicates involve- 
ment  of  polar  lipids  and,  possibly,  the  VLDL 
"apoprotein". Thus far, the complexity and rapid- 
ity (hi2 ~<  60 min) of in vivo VLDL serum turn- 
over (9) has precluded in vivo attempts to inhibit, 
by exogenous VLDL administration,  70%  hepa- 
tectomy-induced DNA synthesis. 
A  simple hypothesis may be that a minor class 
of VLDL lipid  influences membrane events regu- 
lating critical protein synthetic steps required  for 
initiating  DNA  synthesis.  Consequently,  a  "re- 
gion" of hepatocyte membrane lipid, rather than a 
defined protein receptor, may confer "specificity" 
to VLDL action.  Alternatively,  inhibitory action 
of VLDL polar lipid(s) may be a consequence of 
surface active effects resulting from emulsification 
procedures.  However,  neutral  lipid  emulsions, 
which probably are taken up and metabolized by 
the cells,  had no biological activity under similar 
conditions (Fig. 6). Furthermore, release of cyto- 
toxic-free fatty acids subsequent to cell-mediated 
VLDL hydrolysis is unlikely because of the pres- 
ence of albumin in the culture fluids (22, 40).  It 
has not yet been determined whether the aqueous 
wash  fraction  of  VLDL  contains  gangliosides, 
which  also  may play growth-controlling roles  in 
other cell culture systems (3,  16).  However, the 
Sephadex  column  purification-step  clearly  elim- 
inates  other low  molecular weight  water-soluble 
factors. Because LDL and HDL emulsified lipids 
are inactive, their major lipid classes, which also 
are present in VLDL, probably are not involved 
(again,  this  assumes  intracellular  availability). 
Functions  associated  with  VLDL  apoprotein 
moieties include the capacity for activation of leci- 
thin:cholesterol  acyl transferase  (10);  for activa- 
tion of lipoprotein lipase  (15); and,  possibly, for 
cholesterol transport  into  cells  or exchange  with 
plasma membranes (4). Thus, if apoprotein inhibi- 
tion  (Fig.  6)  does  not  result  from  bound  lipid 
contamination,  its  action  also  could  be  through 
modification of hepatic membrane structure. 
Two predictions follow from the above discus- 
sion. First,  hepatic VLDL production should oc- 
cur predominantly during Go (and/or early G1)6; 
therefore,  intrahepatic  and  serum  VLDL  levels 
should  be  inversely  related  to  hepatic  growth 
states. This prediction is supported by the obser- 
vation  that  rapid,  specific,  and  persistent  de- 
creases  in  serum  VLDL levels  occur after  70% 
hepatectomy  in  adult  rats  (Fig.  7).  Moreover, 
these  kinetic changes could have  been predicted 
partly from the rapid elevation of serum glucagon 
occurring after partial  hepatectomy (27,  29)  be- 
cause  hyperglucagonemic states  suppress hepatic 
VLDL production (8).  However, growth regula- 
tion by glucagon is probably complex (6, 27), and 
other factors, including prostaglandin-El, heparin 
production by mast cells,  and alpha~-fetoprotein, 
also may be involved with suppression of hepatic 
VLDL production (27, 28). In addition, fetal rat 
serum VLDL levels are significantly less (by 70- 
As yet, we have been unable to detect newly synthe- 
sized  VLDL  in  "quiescent"  fetal  hepatocyte  culture 
fluids, although active synthesis and secretion of other 
liver-specific proteins occurs (22, 24, 40). By contrast, 
adult hepatocyte cultures produce VLDL (D. Weinstein, 
unpublished observations) but do not grow (1). 
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tally as hepatic DNA synthesis declines (11,41).7 
Second,  genetic  and/or  environmental condi- 
tions  which  specifically  raise  or  lower  hepatic 
VLDL production and secretion should retard or 
promote, respectively, initiation of hepatic DNA 
synthesis.  Results with  70%  hepatectomized  hy- 
perlipoproteinemic  mutant  rats  (Table  I),  with 
adult rats  infused with a  TAGH  solution (Table 
II),  and  with  choline-deficient animals  7 tend  to 
support this prediction. 
Fatty rats  are  hyperinsulinemic (56),  overpro- 
duce VLDL (38), and have elevated serum VLDL 
levels (39). Because peripheral antilipolytic effects 
of insulin could limit fatty acid supplies to regener- 
ating liver which, in turn, may be growth regula- 
tory (27, 44), it cannot yet be concluded that low 
DNA  synthesis  rates  observed  in  70%  hepatec- 
tomized mutant rats result solely from VLDL ac- 
tion.  However,  the  ability  of  these  animals  to 
regulate  peripheral  VLDL  and  insulin  levels 
seems intact because, as in normal rats (29), lower 
posthepatectomy  insulin (not shown) and VLDL 
levels (Table  I) were  observed.  Whether or not 
prolonged  onset  times  and/or  decreased  recruit- 
ment of DNA-synthesizing cells cause decreased 
DNA synthesis rates is, as yet, unknown. 
TAGH  infusions stimulate  hepatic  DNA  syn- 
thesis  fivefold  and  rapidly  lower  serum  VLDL 
(Table II) as predicted (27). Although each com- 
ponent of the  infusate contributes to stimulating 
DNA  synthesis  (42),  it  is  not  yet  known which 
single  or  combined  components  lower  serum 
VLDL;  likely  candidates  are  glucagon  (8)  and 
heparin  (11).  Causal  relationships  between 
TAGH-induced depression of serum VLDL levels 
and  induction  of  DNA  synthesis  would  seem 
likely,  but  other  direct  hepatoceUular  effects  of 
infusate components unrelated to VLDL metabo- 
lism also  could  be  important  (e.g.  putative tem- 
plate  activity  of  heparin  [21]).  However,  both 
glucagon and heparin (26) fail to initiate in vitro 
hepatocyte DN A synthesis under a variety of con- 
ditions. 
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